Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. Dezember 2025 13:30 ET | Quelle: Merakris Therapeutics

Merakris Therapeutics Chief Scientific Officer Dr. Roger Ilagan to Present at Innovations in Wound Healing Symposium

RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics, a regenerative medicine company developing biologic drug therapies for hard-to-heal wounds, announces that...
10. April 2025 06:30 ET | Quelle: Merakris Therapeutics

Merakris Therapeutics Appoints Roger Ilagan to Chief Scientific Officer

RESEARCH TRIANGLE PARK, N.C., April 10, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics has named Roger Ilagan, PhD as its new Chief Scientific Officer (CSO). Responsible for guiding the biologic...
05. Dezember 2023 06:30 ET | Quelle: Merakris Therapeutics

Merakris To Share Data from Fully Enrolled First Part of Two-Part Dermacyte® Liquid Clinical Trial

Merakris Therapeutics announces it has fully enrolled the first part of a clinical trial to evaluate its investigational drug product, Dermacyte® Liquid.
20. September 2021 09:05 ET | Quelle: CMI

Vascular Ulcers Treatment Market to Surpass US$ 5.08 Billion by end of 2028, Says Coherent Market Insights (CMI)

SEATTLE, Sept. 20, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global vascular ulcers treatment market is estimated to be valued at US$ 3.36 billion in 2021 and is expected...